definiens: in a country is defined as a Third Party ’s ( or ThirdParties ’ ) sales of a generic product containing the same Collaboration Clinical Candidate as found in the CollaborationProduct in question ( whether alone or in combination with other therapeutically active compounds ) reaching a marketshare in such country greater than or equal to [ * * * ] of [COMPANY] ’s unit sales of the Collaboration Product in suchcountry, without obtaining a license from [COMPANY] . It is understood that [COMPANY] shall continue to pay the Ambitroyalties on Net Sales of a Collaboration Product within any given country at the full rates otherwise applicable underthis Agreement, until such time as [COMPANY] has determined and confirmed in writing to Ambit, subject to reasonableverification, that there is Substantial Generic Competition with respect to a particular Collaboration Product in suchcountry . At such time, subject to Section 11.3.8, [COMPANY] may reduce the payment of royalties to Ambit in suchcountry with respect to such Collaboration Product pursuant to this Section